Por favor, use este identificador para citar o enlazar este ítem:
https://repositorio.uca.edu.ar/handle/123456789/8782
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Di Rosso, María Emilia | es |
dc.contributor.author | Palumbo, María Laura | es |
dc.contributor.author | Genaro, Ana María | es |
dc.date.accessioned | 2019-09-23T18:05:01Z | - |
dc.date.available | 2019-09-23T18:05:01Z | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | Di Rosso ME, Palumbo ML, Genaro AM. Immunomodulatory effects of fluoxetine : a new potential pharmacological action for a classic antidepressant drug? [en línea]. Pharmacological Research. 2016;109:101-107. doi:10.1016/j.phrs.2015.11.021 Disponible en: https://repositorio.uca.edu.ar/handle/123456789/8782 | es |
dc.identifier.issn | 1043-6618 (impreso) | - |
dc.identifier.issn | 1096-1186 (online) | - |
dc.identifier.uri | https://repositorio.uca.edu.ar/handle/123456789/8782 | - |
dc.description.abstract | Abstract: Selective serotonin reuptake inhibitors are frequently used antidepressants. In particular, fluoxetine is usually chosen for the treatment of the symptoms of depression, obsessive-compulsive, panic attack and bulimia nervosa. Antidepressant therapy has been associated with immune dysfunction. However, there is contradictory evidence about the effect of fluoxetine on the immune system. Experimental findings indicate that lymphocytes express the serotonin transporter. Moreover it has been shown that fluoxetine is able to modulate the immune function through a serotonin-dependent pathway and through a novel independent mechanism. In addition, several studies have shown that fluoxetine can alter tumor cell viability. Thus, it was recently demonstrated in vivo that chronic fluoxetine treatment inhibits tumor growth by increasing antitumor T-cell activity. Here we briefly review some of the literature referring to how fluoxetine is able to modify, for better or worse, the functionality of the immune system. These results of our analysis point to the relevance of the novel pharmacological action of this drug as an immunomodulator helping to treat several pathologies in which immune deficiency and/or deregulation is present. | es |
dc.format | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | Elsevier | es |
dc.rights | Acceso abierto. 12 meses de embargo | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
dc.source | Pharmacological Research. 2016;109:101-107 | es |
dc.subject | ANTIDEPRESIVOS | es |
dc.subject | DEPRESION | es |
dc.subject | SISTEMA INMUNOLOGICO | es |
dc.subject | SEROTONINA | es |
dc.title | Immunomodulatory effects of fluoxetine : a new potential pharmacological action for a classic antidepressant drug? | es |
dc.type | Artículo | es |
dc.identifier.doi | 10.1016/j.phrs.2015.11.021 | - |
dc.identifier.pmid | 26644208 | - |
uca.disciplina | MEDICINA | es |
uca.issnrd | 1 | es |
uca.affiliation | Fil: Di Rosso, María Emilia. Pontificia Universidad Católica Argentina. Facultad de Ciencias Médicas. Instituto de Investigaciones Biomédicas; Argentina | es |
uca.affiliation | Fil: Di Rosso, María Emilia. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | es |
uca.affiliation | Fil: Palumbo, María Laura. Universidad Nacional del Noroeste de la Provincia de Buenos Aires. Centro de Investigaciones y Transferencia del Noroeste de la Provincia de Buenos Aires; Argentina | es |
uca.affiliation | Fil: Palumbo, María Laura. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | es |
uca.affiliation | Fil: Genaro, Ana María. Pontificia Universidad Católica Argentina. Facultad de Ciencias Médicas. Instituto de Investigaciones Biomédicas; Argentina | es |
uca.affiliation | Fil: Genaro, Ana María. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | es |
uca.affiliation | Fil: Genaro, Ana María. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Farmacología; Argentina | es |
uca.version | acceptedVersion | es |
item.fulltext | With Fulltext | - |
item.grantfulltext | open | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Instituto de Investigaciones Biomédicas - BIOMED | - |
crisitem.author.dept | Laboratorio de Psiconeuroendocrinoinmunología | - |
crisitem.author.dept | Consejo Nacional de Investigaciones Científicas y Técnicas | - |
crisitem.author.dept | Facultad de Ciencias Médicas | - |
crisitem.author.dept | Facultad de Ciencias Médicas | - |
crisitem.author.dept | Instituto de Investigaciones Biomédicas - BIOMED | - |
crisitem.author.dept | Laboratorio de Psiconeuroendocrinoinmunología | - |
crisitem.author.orcid | 0000-0003-0027-3503 | - |
crisitem.author.parentorg | Facultad de Ciencias Médicas | - |
crisitem.author.parentorg | Instituto de Investigaciones Biomédicas - BIOMED | - |
crisitem.author.parentorg | Pontificia Universidad Católica Argentina | - |
crisitem.author.parentorg | Pontificia Universidad Católica Argentina | - |
crisitem.author.parentorg | Facultad de Ciencias Médicas | - |
crisitem.author.parentorg | Instituto de Investigaciones Biomédicas - BIOMED | - |
Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
immunomodulatory-effects-fluoxetine-new.pdf | 590,94 kB | Adobe PDF | Visualizar/Abrir | |
immunomodulatory-effects-fluoxetine-new.jpg | 3,73 kB | JPEG | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons